Unknown

Dataset Information

Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers.


ABSTRACT:

Background

Identification of BRCA mutations in breast cancer (BC) patients influences treatment and survival and may be of importance for their relatives. Testing is often restricted to women fulfilling high-risk criteria. However, there is limited knowledge of the sensitivity of such a strategy, and of the clinical aspects of BC caused by BRCA mutations in less selected BC cohorts. The aim of this report was to address these issues by evaluating the results of BRCA testing of BC patients in South-Eastern Norway.

Methods

1371 newly diagnosed BC patients were tested with sequencing and Multi Ligation Probe Amplification (MLPA). Prevalence of mutations was calculated, and BC characteristics among carriers and non-carriers compared. Sensitivity and specificity of common guideli

SUBMITTER: Grindedal EM 

PROVIDER: S-EPMC5480128 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature